Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
43.03
-0.66 (-1.51%)
At close: Nov 17, 2026, 4:00 PM EST
42.85
-0.18 (-0.42%)
Pre-market: Nov 18, 2026, 4:39 AM EST
Boston Scientific Revenue
Boston Scientific had revenue of $5.14B in the quarter ending September 30, 2026, with 1.44% growth. This brings the company's total for the last twelve months to $21.07B, up 8.88% year-over-year. In the year 2025, Boston Scientific had annual revenue of $20.07B with 19.87% growth. That makes Boston Scientific the 725th largest company in the world by revenue and 241st in the United States.
Revenue (ttm)
$21.07B
Revenue Growth
+8.88%
P/S Ratio
2.96
Revenue / Employee
$357,119
Employees
59,000
Market Cap
62.37B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Boston Scientific breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.07B | 3.33B | 19.87% |
| Dec 31, 2024 | 16.75B | 2.51B | 17.61% |
| Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
| Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
| Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
| Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
| Dec 31, 2019 | 10.74B | 912.00M | 9.28% |
| Dec 31, 2018 | 9.82B | 775.00M | 8.57% |
| Dec 31, 2017 | 9.05B | 662.00M | 7.89% |
| Dec 31, 2016 | 8.39B | 909.00M | 12.16% |
| Dec 31, 2015 | 7.48B | 97.00M | 1.31% |
| Dec 31, 2014 | 7.38B | 237.00M | 3.32% |
| Dec 31, 2013 | 7.14B | -106.00M | -1.46% |
| Dec 31, 2012 | 7.25B | -373.00M | -4.89% |
| Dec 31, 2011 | 7.62B | -184.00M | -2.36% |
| Dec 31, 2010 | 7.81B | -382.00M | -4.67% |
| Dec 31, 2009 | 8.19B | 138.00M | 1.71% |
| Dec 31, 2008 | 8.05B | -307.00M | -3.67% |
| Dec 31, 2007 | 8.36B | 536.00M | 6.85% |
| Dec 31, 2006 | 7.82B | 1.54B | 24.48% |
| Dec 31, 2005 | 6.28B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories | 48.23B |
| Medtronic | 37.54B |
| Stryker | 26.30B |
| GE HealthCare Technologies | 21.64B |
| Koninklijke Philips | 20.16B |
| Zimmer Biomet Holdings | 8.57B |
| Edwards Lifesciences | 6.67B |
| Smith & Nephew | 6.30B |
BSX News
- 1 day ago - Boston Scientific management to meet with Oppenheimer - TheFly
- 6 days ago - Boston Scientific Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 15 days ago - Blackstone Life Sciences announces $455M collaboration with Boston Scientific - TheFly
- 15 days ago - Blackstone Life Sciences announces $455M collaboration with Boston Scientific - TheFly
- 15 days ago - Blackstone Life Sciences Announces $455 Million Collaboration to Co-Fund Development of Boston Scientific VITALYST™ Heart Pump for Patients with Cardiogenic Shock - Business Wire
- 15 days ago - SIMPLAAFY study of the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device meets primary endpoints - PRNewsWire
- 19 days ago - Boston Scientific price target lowered to $45 from $48 at Barclays - TheFly
- 19 days ago - Boston Scientific downgraded to Hold from Buy at TD Cowen - TheFly